[1] Jinek, M., Chylinski, K. and Fonfara, I. (2012). A programmable dual- RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 337; 816–821.
[2]
Ishino, Y.,
Shinagawa, H.,
Makino, K.,
Amemura, M. and
Nakata, A. (1987). “Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product”. Journal of Bacteriology. 169; 5429–5433.
[3] Barrangou,
R, Christophe, F., Hélène,
D., Melissa, R., Patrick, B.; Sylvain, M.; Dennis, A. and Philippe,
H.(2007). “CRISPR provides acquired resistance against viruses in prokaryotes”. Science. 315(5819); 1709–1712.
[4] Cong, L., Ran, F. and Cox, D. (2013). “Multiplex genome engineering using CRISPR/Cas systems”. Science. 339; 819–823.
[5] Hsu, P., Lander, E. and F. Zhang. (2012) “Development and applications of CRISPR-Cas9 for genome engineering”. Cell. 157(6); 1262–1278.
[6] Xingliang, M., Qunyu, Z., Qinlong, Z.,Wei, L., Yan, C.; Rong, Q., Bin, W., Zhongfang, Y., Heying, L., Yuru, L., Yongyao, X., Rongxin, S., Shuifu, C., Zhi, W, Yuanling, C.,Jingxin, G., Letian, C., Xiucai, Z., Zhicheng, D. and Yao-Guang, L.(2015). “A robust CRISPR/Cas9 system for convenient high efficiency multiplex genome editing in monocot and dicot plants”, Molecular Plant. 8;1274–1284.
[7] Dominguez, A., Lim, W. and Qi, L. (2016). “Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation”, Nat. Rev. Mol. Cell Biology.17(1); 5–15.
[8] Komor, A., Kim, Y., Packer, M., Zuris, J. and Liu, D. (2016). “Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage”, Nature. 533(7603) ; 420-424.
[9] Hu, J, Miller, S., Geertz, M., Tang, W,Chen, L.; Sun, N.; Zeina, C.; Gao, X.; Rees, H.; Lin, Z. and Liu, D. (2018).“Evolved Cas9 variants with broad PAM compatibility and high DNA specificity”. Nature. 556(7699),57-63.
[10] Yang, N, Wang, R. and Zhao,Y.(2017). “Revolutionize genetic studies and crop improvement with high-throughput and genome-cale CRISPR/Cas9 gene editing technology”. Molecular Plant. 10 (9); 1141–1143.
[11] Gao, Y., Zhang, Y., Zhang, D., Dai, X., Estelle, M. and Zhao,Y. (2017). “Auxin binding protein 1 (ABP1) is not required for either auxin signaling or Arabidopsis development”. Proceedings of the National Academy of Sciences.112 (7) ; 2275–2280.
[12] Tang, X., Lowder, L., Zhang, T.,Malzahn, A.; Zheng, X.; Voytas, D.; Zhong, Z.; Chen, Y.; Ren, Q.; Li, Q.; Kirkland, E.; Zhang, Y. and Qi., Y.(2017). “A CRISPR-Cpf1 system for efficient genome editing and transcriptional repression in plants”. Nature Plants. 3; 17103.
[13] Mali, P., Yang, L, Esvelt, K., Aach, J., Guell, M.; Di Carlo, J.; Norville, E. and Church. M. (2013). “RNA-guided human genome engineering via Cas9”. Science. 339 (6121);823–826.
[14] He, Y., Wang, R., Dai, X. and Zhao, Y. (2017). “On improving CRISPR for editing plant genes: ribozyme-mediated guide RNA production and fluorescence-based technology for isolating transgene-free mutants generated by CRISPR”. Molecular Biology and Translational Science.149; 151–166.
[15] Di Cristina, M. and Carruthers, V.B. (2018). “New and emerging uses of CRISPR/Cas9 to genetically manipulate apicomplexan parasites”. Parasitology. 145;1119–1126.
[16] Darde, M,Bouteille, B. and Pestre-Alexandre, M.(1988). “Isoenzymic characterization of seven strains of Toxoplasma gondii by iso- electrofocusing in polyacrylamide gels”. The American Journal of Tropical Medicine and Hygiene 39(6); 551-558.
[17] Darde, M. Bouteille, B. and Pestre-Alexandre,M. (1992). “Isoenzyme analysis of 35 Toxoplasma gondii isolates and the biological and epidemiological implications”. Journal of Parasitology. 78; 786-794
[18] Howe, D. and Sibley, L. (1995). “Toxoplasma gondii comprises 3 clonal lineages correlation of parasite genotype with human disease”. Journal of Infectious Diseases. vol.172, 1561-1566.
[19] Lehmann, T., Blackston, C.,Parmley, S., Remington, J. and Dubey,J. (2000). “Strain typing of Toxoplasma gondii: comparison of antigen-coding and housekeeping genes”. Journal of Parasitology. 86; 960-971.
[20] Ajzenberg, D.; Banuls, A.; Tibayrenc, M. and Darde, M. (2002). “Microsatellite analysis of Toxoplasma gondii shows considerable polymorphism structured into two main clonal groups”. International Journal for Parasitology. 32; 27-38.
[21] Grigg, M.; Bonnefoy, S., Hehl, A., Suzuki, Y. and Boothroyd, J. (2001). “Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries”. Science. 294;161-165.
[22] Su, C., Asis, K.; Peng, Z., Debashree, M, Daniel, A., Marie-Laure, D., Xing-Quan , Z, James, W. , Benjamin, M., Dubey, and L. Sibley, D.(2012). “Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages”. Proceedings of the National Academy of Sciencesdoi: 10.1073/pnas.1203190109.
[23] Wilson, R. and Williamson, H. (1997). “Extra chromosomal DNA in the Apicomplexa”. Microbiology and Molecular Biology. 61;1-16.
[24] Lau, Y.,Lee, W., Gudimella, R., Zhang, G., Ching, X. and Razali, R.(2016). “Deciphering the Draft Genome of Toxoplasma gondii RH Strain”, plos one. 11, (6); e0157901.
[25] Sibley,D. and Boothroyd, J.(1992) “Construction of a molecular karyotype for Toxoplasma gondii”, Molecular and Biochemical Parasitology. 51; 291-300.
[26] Khan, A., Taylor, S., Su, C., Mackey, A., Boyle, J., Cole, R. and Glover, D. (2005). “Composite genome map and recombination parameters derived from three archetypal lineages of Toxoplasma gondii”, Nucleic acids research. 33(9); 2980–2992.
[27] Pfefferkorn, L. and Pfefferkorn, E. (1980). “Toxoplasma gondii: genetic recombination between drug resistant mutants”. Experimental Parasitology. vol.50, 305-316.
[28] Jiménez-Ruiz, E. H. Eleanor, Wong, G., Pall, S. and Markus, M. (2014). “Advantages and Disadvantages of Conditional Systems for Characterization of Essential Genes in Toxoplasma gondii”. Parasitology. 141(11); 1390–1398.
[29] Ajioka, J., Fitzpatrick, J. and Reitter, C. (2001). “Toxoplasma gondii genomics: Shedding light on pathogenesis and chemotherapy”. Expert Reviews in molecular medicine.3(1); 1-19.
[30] Striepen, B., Crawford, M., Shaw, M.,Tilney, L.; Seeber, F. and Roos, D. (2000). “The plastid of Toxoplasma gondii is divided by association with the centrosomes”. The Journal of cell biology.151 (7) ; 1423–1434.
[31] Louis, M. and Kim, K. (2020). “Toxoplasma gondii The Model Apicomplexan: Perspectives and Methods”, Academic Press. 801.
[32] Yung, S. and Lang-Unnasch, N. (2004). “Targeting the toxoplasma gondii apicoplast for chemotherapy”. In: Lindsay, D. and Weiss L. (eds) “Opportunistic Infections: Toxoplasma, Sarcocystis, and MicrosporidiaSpringer, M.A. Boston.
[33] Tjhin, E., Hayward, J., McFadden, G. and van Dooren, G.(2020). “Characterization of the apicoplast-localized enzyme TgUroD in Toxoplasma gondii reveals a key role of the apicoplast in heme biosynthesis”. The Journal of Biological Chemistry. 295(6); 1539‐1550.
[34] Flegontov, P., Michalek, J., Janouskovec, J., Lai, D., Jirku, M.; Hajduskova, E, Tomcala, A., Otto, T., Keeling, P. and Pain, A. (2015). “Divergent mitochondrial respiratory chains in phototrophic relatives of apicomplexan parasites”. Molecular biology and evolution.32; 1115-1131.
[35] Garbuz, T. and Arrizabalaga, G. (2017). “Lack of mitochondrial MutS homolog 1 in Toxoplasma gondii disrupts maintenance and fidelity of
mitochondrial DNA and reveals metabolic plasticity”. PLoS ONE. 12(11); e0188040
[36] Lorenzi, H., Khan, A., Behnke, M., Namasivayam, S., Swapna, L, Hadjithomas, M., Karamycheva, S, Pinney, D., Brunk, B, and Ajioka,J. (2016). “Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii”. Nature Communication. 7;10147.
[37] Syn, G.,Anderson, D., Blackwell, J. and Jamieson, S.(2017). “Toxoplasma gondii Infection Is Associated with Mitochondrial Dysfunction in-Vitro. Front”. Cellular and infection microbiology. 7; 512.
[38] Zı´kova´, A, Hampl, V, Paris, Z., Tyc, J.and Lukesˇ, J. (2016). “Aerobic mitochondria of parasitic protists: Diverse genomes and complex functions”, Molecular and Biochemical Parasitology. 206; 46–57.
[39] Chen, H.; Guo, Y. and Qiu, Y. (2019).” Efficient genome engineering of Toxoplasma gondii using the TALEN technique”, Parasites Vectors. 12, 112.
[40] Zhao, G.; Pu, J. and Tang, B. (2016). “Coding mutations inNUS1contribute to Parkinson’s disease”. Proceedings of the national academy of sciences. 33(6);857‐862.
[41] Sidik, S.; Hackett, C.; Tran, F.; Westwood, N. and Lourido, S. (2014). “Efficient Genome Engineering of Toxoplasma gondii Using CRISPR/ Cas9”. PLoS ONE. 9)6); e 100450.
[42] Kirkman, L.; Lawrence, E. and Deitsch, K. (2014). “Malaria parasites utilize both homologous recombination and alternative end joining pathways to maintain genome integrity”. Nucleic Acids Research. 42; 370 –379
[43] Wang, J.; Huang, S.; Behnke, M.; Chen, K.; Shen, B. and Zhu, X. (2016). “The past, present, and future of genetic manipulation in Toxoplasma gondii”. Trends in Parasitology. 32;542–553.
[44] Shen, B.,Brown, K., Lee, T. and Sibley, L. (2014). “Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9”. Molecular biology. 5 (3); e01114-14.
[45] Behnke, M., Khan, A., Lauron, E., Jimah, J,Wang, Q. and Tolia, N.(2015). “Rhoptry Proteins ROP5 and ROP18 Are Major Murine Virulence Factors in Genetically Divergent South American Strains of Toxoplasma gondii”. PLoS Genetics. 11(8); e1005434.
[46] Zheng, J.; Jia, H. and Zheng, Y. (2015). “Knockout of leucine aminopeptidase in Toxoplasma gondii using CRISPR/Cas9”. International Journal for Parasitology. 45)2-3); 141‐148.
[47] Foroutan, M. and Ghaffarifar, F. (2018). “Calcium-dependent protein kinases are potential targets for Toxoplasma gondii vaccine”. Clinical and Experimental Vaccine Research. 7 (1) ; 24‐36.
[48] Long, S.,Wang, Q. and Sibley, L. (2016). “Analysis of non-canonical calcium dependent protein kinases in Toxoplasma gondii by targeted gene deletion using CRISPR/Cas9”. Infection and Immunity. 84, 1262–1273.
[49] Sidik, S.; Huet, D.; Ganesan, S.; Huynh, M.; Wang, T.; Nasamu, A.; Thiru, P.; Saeij, J.; Carruthers, V.; Niles, J. and Lourido, S.(2016). “Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes”. Cell. 166 (6);1423-1435.
[50] Sidik, S.; Huet, D. and Lourido,S.(2018).“CRISPR/Cas9-based genome-wide screening of Toxoplasma gondii”. Nature Protocol. 13(1); 307–323.
[51] Young, J.; Dominicus, C. and Wagener, J.(2019). “A CRISPR platform for targeted in vivo screens identifies Toxoplasma gondii virulence factors in mice”. Nature Communiication. 10; 3963.